Lynda L. Perry
FDA investigator
Appears on 2 documents from 2015 to 2016, mostly at sites in Washington. Most often cites written procedures; deviations (21 CFR 211.100).
- 2
- Documents on file
- 2.0
- Observations per 483
- 2015
- First seen
- 2016
- Most recent
What they cite most
From 4 observations- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.180General requirements1
- 21 CFR 211.192Production record review1
Activity by year
2015: 1, 2016: 1
Where
Washington 2
Often inspects with
Is Lynda L. Perry coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2016-09-30 | 483 Jubilant HollisterStier LLCSep 30, 2016 · Spokane, Washington | Spokane, Washington | 3 | |
| 2015-07-31 | 483 Jubilant HollisterStier LLCJul 31, 2015 · Spokane, Washington | Spokane, Washington | 1 |
About this profile
What does Lynda L. Perry inspect?
Lynda L. Perry appears on 2 documents on file covering 1 site, mostly in Washington.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.180 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Lynda L. Perry is dated Sep 30, 2016.